Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 51.6 | 2.65% | 1.33 |
SBIO closed up 2.65 percent on Friday, March 5, 2021, on 2.18 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Historical SBIO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Volume Surge | Other | 2.65% | |
| Lower Bollinger Band Walk | Weakness | 2.65% | |
| Multiple of Ten Bullish | Other | 2.65% | |
| Below Lower BB | Weakness | 2.65% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Up 2% | 1 day ago | |
| 60 Minute Opening Range Breakout | 1 day ago | |
| Up 1% | 1 day ago | |
| Reversed from Down | 1 day ago | |
| Down 1 ATR | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Top 10 Components
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 64.04 |
| 52 Week Low | 25.1 |
| Average Volume | 38,378 |
| 200-Day Moving Average | 46.74 |
| 50-Day Moving Average | 56.33 |
| 20-Day Moving Average | 57.78 |
| 10-Day Moving Average | 54.73 |
| Average True Range | 2.19 |
| ADX | 36.3 |
| +DI | 13.69 |
| -DI | 44.51 |
| Chandelier Exit (Long, 3 ATRs ) | 57.48 |
| Chandelier Exit (Short, 3 ATRs ) | 54.52 |
| Upper Bollinger Band | 65.10 |
| Lower Bollinger Band | 50.46 |
| Percent B (%b) | 0.08 |
| BandWidth | 25.33 |
| MACD Line | -1.35 |
| MACD Signal Line | -0.31 |
| MACD Histogram | -1.0341 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 57.08 | ||||
| Resistance 3 (R3) | 56.47 | 54.04 | 56.16 | ||
| Resistance 2 (R2) | 54.04 | 52.65 | 54.34 | 55.86 | |
| Resistance 1 (R1) | 52.82 | 51.78 | 53.43 | 53.43 | 55.55 |
| Pivot Point | 50.39 | 50.39 | 50.70 | 50.69 | 50.39 |
| Support 1 (S1) | 49.17 | 49.00 | 49.78 | 49.78 | 47.65 |
| Support 2 (S2) | 46.74 | 48.13 | 47.04 | 47.34 | |
| Support 3 (S3) | 45.52 | 46.74 | 47.04 | ||
| Support 4 (S4) | 46.13 |
